-+ 0.00%
-+ 0.00%
-+ 0.00%

ESPERION THERAPEUTICS: TO RECEIVE UPFRONT PAYMENT & BE ELIGIBLE FOR MILESTONE PAYMENTS OF UP TO ABOUT $5 MLN WITH TIERED ROYALTIES ON PRODUCT SALES

Reuters·05/08/2025 10:30:20

Please log in to view news